Princy Kumar

13.6k total citations · 1 hit paper
127 papers, 3.8k citations indexed

About

Princy Kumar is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Princy Kumar has authored 127 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Infectious Diseases, 54 papers in Virology and 39 papers in Epidemiology. Recurrent topics in Princy Kumar's work include HIV/AIDS drug development and treatment (55 papers), HIV Research and Treatment (54 papers) and HIV/AIDS Research and Interventions (42 papers). Princy Kumar is often cited by papers focused on HIV/AIDS drug development and treatment (55 papers), HIV Research and Treatment (54 papers) and HIV/AIDS Research and Interventions (42 papers). Princy Kumar collaborates with scholars based in United States, France and United Kingdom. Princy Kumar's co-authors include Elaine M. Sloand, Neal S. Young, Frank Weichold, Ann C. Collier, Timothy Flanigan, Leslie A. Kalish, Susan F. Assmann, Frances Wallach, Letty Mintz and Michael F. Para and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Princy Kumar

117 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel

2012 481 citations Princy Kumar et al. profile →

Peers

Countries citing papers authored by Princy Kumar

Since Specialization

Citations

This map shows the geographic impact of Princy Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Princy Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Princy Kumar more than expected).

Fields of papers citing papers by Princy Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Princy Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Princy Kumar. The network helps show where Princy Kumar may publish in the future.

Co-authorship network of co-authors of Princy Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Princy Kumar. A scholar is included among the top collaborators of Princy Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Princy Kumar. Princy Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IL-27 effects on HIVGag-specific CD4 and CD8 T cell function 2025 ·Frontiers in Virology ·(unknown), (unknown), Jie Cheng, C. Christina Mehta, (unknown), Danish Mahmood, Princy Kumar, Marta Catálfamo	0
2	Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3 clinical trials 2025 ·BMC Infectious Diseases ·(unknown), Samir K. Gupta, Princy Kumar, (unknown), (unknown), Hui Liu, Jason T. Hindman, Jürgen K. Rockstroh	0
3	Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control 2024 ·Frontiers in Medicine ·Anshika Jain, Gaspar E. Cánepa, Mei-Ling Liou, (unknown), Andrei I. Chapoval, (unknown), (unknown), (unknown), (unknown), (unknown), Princy Kumar, José Bordón, Marcus A. Conant, Jefferey S. Boyle	1
4	High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre‐existing HIV resistance and suboptimal adherence 2024 ·Journal of Medical Virology ·Kristen Andreatta, Michelle L. D’Antoni, Silvia Chang, (unknown), Ross Martin, Christiana Blair, Debbie Hagins, Princy Kumar, Jason T. Hindman, (unknown), Christian Callebaut	6
5	Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study 2024 ·AIDS and Behavior ·Princy Kumar, Amanda Clarke, (unknown), Miguel García Deltoro, Simona Di Giambenedetto, Carlos Brites, Laurent Hocqueloux, Po‐Liang Lu, J Oyee, Alan Oglesby, Brian Wynne, (unknown), (unknown), (unknown), (unknown), Julie Priest	0
6	Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients 2024 ·Frontiers in Immunology ·Ainhoa Pérez‐Díez, Xiangdong Liu, (unknown), (unknown), Andrea Lisco, (unknown), (unknown), Matthew J. Memoli, Joseph M. Rocco, (unknown), Elizabeth Laidlaw, (unknown), Maura Manion, Glenn Wortmann, Rita Poon, Princy Kumar, Irini Sereti	0
7	1581. Weight and Metabolic Changes with Long-Acting Lenacapavir in a Combination Regimen in Treatment-Naïve People with HIV-1 at Week 80 2023 ·Open Forum Infectious Diseases ·Princy Kumar, Deborah Goldstein, Richard L. Hengel, Aditya H. Gaur, (unknown), (unknown), Cheryl Newman, G. A. Saunders, Shanyu Liu, Hadas Dvory‐Sobol, Martin S. Rhee, Samir K. Gupta	2
8	Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1 2023 ·Infectious Diseases and Therapy ·Judith A. Aberg, (unknown), (unknown), (unknown), (unknown), Christine Katlama, Shannon Schrader, Joseph J. Eron, Princy Kumar, Eduardo Sprinz, Margaret Gartland, (unknown), Andrew Clark, Amy Pierce, Max Lataillade, Allan R. Tenorio	7
9	Cingulate transcranial direct current stimulation in adults with HIV 2022 ·PLoS ONE ·Xiong Jiang, (unknown), (unknown), Fan Yang, John Paul Ryan, (unknown), (unknown), Princy Kumar, David J. Moore, Ronald J. Ellis, Peter E. Turkeltaub	1
10	The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States 2021 ·PharmacoEconomics ·Anita J. Brogan, Sandra E. Talbird, (unknown), Elizabeth M. La, Princy Kumar	3
11	Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus 2021 ·Open Forum Infectious Diseases ·(unknown), Janet Lo, Carlos Malvestutto, Kathleen V. Fitch, Markella V. Zanni, Carl J. Fichtenbaum, Edgar T. Overton, Nwora Lance Okeke, Princy Kumar, Esaú João, Judith A. Aberg, Estebán Martínez, Judith S. Currier, Pamela S. Douglas, Heather J. Ribaudo, Steven Grinspoon	27
12	639. Time to Recurrence of Clostridioides difficile Infection (rCDI) is Rapid Following Completion of Standard of Care Antibiotics: Results from ECOSPOR-III, a Phase 3 Double-Blind, Placebo-Controlled Randomized Trial of SER-109, an Investigational Microbiome Therapeutic 2021 ·Open Forum Infectious Diseases ·Thomas Louie, Matthew Sims, Richard Nathan, (unknown), Princy Kumar, (unknown), (unknown), (unknown), (unknown), Barbara McGovern, Lisa Von Moltke	3
13	Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials 2021 ·BMC Health Services Research ·Andrea Mantsios, Miranda Murray, Tahilin Sanchez Karver, Wendy Davis, Noya Galai, Princy Kumar, Susan Swindells, U. Fritz Bredeek, Rafael Rubio, Antonio Antela, (unknown), (unknown), Maggie Czarnogorski, Krischan J Hudson, (unknown), Deanna Kerrigan	34
14	Low CD4 nadir linked to widespread cortical thinning in adults living with HIV 2019 ·NeuroImage Clinical ·(unknown), Kyle F. Shattuck, (unknown), Matthew Dawson, Monica M. Diaz, Princy Kumar, David J. Moore, Ronald J. Ellis, Xiong Jiang	18
15	Identifying Spatial Variation Along the HIV Care Continuum: The Role of Distance to Care on Retention and Viral Suppression 2018 ·AIDS and Behavior ·Arpi Terzian, Naji Younes, Alan E. Greenberg, Jenevieve Opoku, Julie Hubbard, Lindsey Powers Happ, Princy Kumar, Rena R. Jones, Amanda D. Castel	31
16	Risk Factors for Premature Nuclear Cataract Formation in Human Immunodeficiency Virus (HIV) Infected Individuals Receiving Antiretroviral Therapy 2017 ·Megan K. Morales, (unknown), (unknown), Richard A. Teran, (unknown), Fan Wang, Princy Kumar, Shmuel Shoham, (unknown), Joseph Timpone, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
17	Predictors of response in GRACE (Gender, Race And Clinical Experience) 2009 ·Princy Kumar	2
18	Lamivudine for the treatment of HIV 2009 ·Expert Opinion on Drug Metabolism & Toxicology ·Princy Kumar, Parul Patel	27
19	Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS 1998 ·Clinical Infectious Diseases ·Diane V. Havlir, Michael P. Dubé, J. Allen McCutchan, Donald N. Forthal, Carol A. Kemper, Michael W. Dunne, David M. Parenti, Princy Kumar, A. Clinton White, Mallory D. Witt, Stephen D. Nightingale, Kent A. Sepkowitz, Rob Roy MacGregor, Sarah H. Cheeseman, Francesca J. Torriani, Michael T. Zelasky, Fred R. Sattler, Samuel A. Bozzette	49
20	Primary Cutaneous Acanthamoeba Infection in a Patient with AIDS 1998 ·Clinical Infectious Diseases ·Stephen A. Migueles, Princy Kumar	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact